- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Orbicular Pharmaceutical Technologies covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (93), financial health (95), director (95) and company-foundation signals.
- Operating for 17+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2024.
- Positive net worth.
- 7 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Orbicular Pharmaceutical Technologies
Orbicular Pharmaceutical Technologies is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U24233TG2008PTC060606). Business overview includes Pharma (Pharma Contract R&D), incorporated on August 13, 2008 (18+ years old), headquartered in Hyderabad, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location P.No 53 , Aleap Industrial Estate, Gajularamaram Behind Pragathi Nagar, Kukatpally, Hyderabad, Telangana - 500090
- Website orbicular.co.in
Financial Performance of Orbicular Pharmaceutical Technologies
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Orbicular Pharmaceutical Technologies (7)
Charges of Orbicular Pharmaceutical Technologies
| Lender | Amount | Status |
|---|---|---|
|
Hdfc Bank Limited
Creation Date: 24 Nov 2025 |
40.00 cr | Open |
|
Hdfc Bank Limited
Creation Date: 24 Nov 2025 |
60.00 cr | Open |
|
Others
Creation Date: 30 Oct 2025 |
8.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Professional, Scientific and Technical | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
